BARSOTTI, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 11.220
AS - Asia 1.155
NA - Nord America 1.002
SA - Sud America 78
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 13
Totale 13.485
Nazione #
IT - Italia 11.009
US - Stati Uniti d'America 934
SG - Singapore 508
CN - Cina 268
VN - Vietnam 198
FR - Francia 93
BD - Bangladesh 60
BR - Brasile 44
HK - Hong Kong 41
FI - Finlandia 21
CA - Canada 19
CH - Svizzera 19
MX - Messico 19
AR - Argentina 17
GB - Regno Unito 17
DE - Germania 16
IN - India 13
IQ - Iraq 12
JP - Giappone 10
EC - Ecuador 8
RU - Federazione Russa 8
PK - Pakistan 7
ES - Italia 6
NL - Olanda 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
ID - Indonesia 5
IE - Irlanda 5
JM - Giamaica 5
PH - Filippine 5
CR - Costa Rica 4
HN - Honduras 4
KR - Corea 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
NI - Nicaragua 3
SA - Arabia Saudita 3
UA - Ucraina 3
CO - Colombia 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
SE - Svezia 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
TR - Turchia 1
VI - Stati Uniti Isole Vergini 1
Totale 13.472
Città #
Genova 6.503
Genoa 2.472
Rapallo 1.228
Vado Ligure 725
San Jose 339
Singapore 255
Lauterbourg 85
Ashburn 65
Ho Chi Minh City 64
Hanoi 45
New York 44
Beijing 37
Hong Kong 35
Bordighera 30
Santa Clara 24
Helsinki 21
Los Angeles 20
Zurich 19
Frankfurt am Main 14
Orem 13
Dallas 11
Mexico City 11
Da Nang 10
Phoenix 10
Tianjin 10
Tokyo 10
Chennai 7
Milan 7
Rome 7
Atlanta 6
Charlotte 6
Guangzhou 6
Haiphong 6
Houston 6
Princeton 6
Queens 6
Quito 6
São Paulo 6
Amsterdam 5
Buffalo 5
Chicago 5
London 5
Montreal 5
Poplar 5
Cincinnati 4
Dublin 4
El Paso 4
Jacksonville 4
Kansas City 4
Manchester 4
Minneapolis 4
Paris 4
Raleigh 4
San José 4
Baghdad 3
Biên Hòa 3
Boardman 3
Campinas 3
Can Tho 3
Chongqing 3
Hải Dương 3
Johannesburg 3
Kingston 3
Louisville 3
Managua 3
Miami 3
Orlando 3
San Francisco 3
São Bernardo do Campo 3
Toronto 3
West Hartford 3
Asheboro 2
Baltimore 2
Bari 2
Bengaluru 2
Bologna 2
Boston 2
Bristol 2
Brooklyn 2
Bắc Giang 2
Cape Town 2
Casablanca 2
City of London 2
Concepción 2
Council Bluffs 2
Dubai 2
Eastman 2
Elgin 2
Eureka 2
Everett 2
Florence 2
Go Vap 2
Greenville 2
Grove 2
Guarulhos 2
Hialeah 2
Hixson 2
Jandira 2
Kennesaw 2
Kyiv 2
Totale 12.354
Nome #
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 235
ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells. 217
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 204
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 202
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 193
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 188
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. 186
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 184
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 184
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 184
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 183
Increased neutrophil lifespan in patients with congestive heart failure. 183
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 183
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 181
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 181
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 179
Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. 174
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 173
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 172
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 167
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 165
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 160
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. 159
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 157
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 156
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 156
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 153
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 153
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 153
Early Age of onset of unstable angina is associated to major oxidative stress 153
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 153
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 151
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 149
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 149
Biliopancreatic diversion reduces QT interval and dispersion in morbidly obese patients 146
MR EVALUATION OF CORONARY STENTS WITH NAVIGATOR ECHO AND BREATH-HOLD CINE GRADIENT-ECHO TECHNIQUES 143
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 141
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 140
OxLDL- and HSP-60 antigen-specific CD8(+) T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. 140
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 138
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 137
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 137
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 135
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 132
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 131
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 131
Early age of onset of unstable angina is associated with major oxidative stress 131
Accuracy of noninvasive monitoring of coronary flow velocity reserve with transthoracic echo-doppler in detecting coronary restenosis after successfull coronary angioplasty: a multicenter study 130
A PATHOGENETIC HYPOTHESIS ABOUT ELECTRIC STORM. 130
Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. 129
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 125
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 123
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 122
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 120
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 120
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 119
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 118
Improved assessment of left ventricular volumes and ejection fraction by contrast enhanced harmonic color Doppler echocardiography 118
Cor triatratum sinistrum and persistent left superior vena cava: an original association. 114
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 113
Oxidative stress, apoptosis and immunological activation in acute myocardial infarction 112
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 112
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 112
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 109
Thrombus determinants of vascular cell activation. 109
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 106
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 106
Transcatheter occlusion of PFO and ASD in cryptogenic stroke 105
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 105
Coronary aneurysms and stenosis detected with magnetic resonance coronary angiography in a patient with Kawasaki disease. 105
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study 104
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 103
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 103
Doxorubicin induces LOX-1 expression in cardiac myocytes via oxidative stress: role of cardioprotective agents 103
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 103
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 102
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 102
Time-course of acute myocardial infarction-dependent peripheral mobilisation of endothelial progenitor cells 101
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 100
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 97
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 96
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 95
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 95
Mobilizzazione ematica di sottopopolazioni di progenitori di cellule endoteliali in pazienti con infarto acuto del miocardio 94
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 94
Dispersione del QT in Soggetti con Insufficienza Renale Cronica Trattati con Dialisi Peritoneale o con Emodialisi. 93
Prevalence of persistent left superior vena cava and its implication in pacemaker implantation 93
Myocardial magnetic resonance spectroscopy 93
Evaluation of Xa/Va activity bound to platelet-rich thrombi in patients with acute coronary syndromes 91
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 89
La doxorubicina induce l’espressione di LOX-1R in cellule muscolari cardiache attraverso un incremento dello stress ossidativo: ruolo di molecole cardioprotettive 89
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 88
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 87
Up-regulation of lectin-like oxidised LDL receptor-1 (LOX-1) in cardiac muscle cells and implications in doxorubicin-induced cardiotoxicity. 86
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 86
Involvement of neutrophils and of C-C chemokines in chronic heart failure 83
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 81
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 80
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 75
Primary percutaneous transluminal angioplasty in the setting of multivessel disease 74
Totale 13.144
Categoria #
all - tutte 40.770
article - articoli 33.267
book - libri 0
conference - conferenze 7.503
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.205 9 102 84 159 68 65 76 308 23 121 45 145
2022/20231.430 130 78 6 161 280 239 6 106 231 5 165 23
2023/2024598 23 83 10 54 52 129 37 37 59 7 32 75
2024/20251.727 46 128 59 137 258 163 145 240 56 79 180 236
2025/20262.896 382 60 99 214 311 321 566 138 158 326 99 222
2026/2027318 318 0 0 0 0 0 0 0 0 0 0 0
Totale 13.485